BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29596938)

  • 1. Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation.
    Piao X; Miura R; Miyake S; Komazawa-Sakon S; Koike M; Shindo R; Takeda J; Hasegawa A; Abe R; Nishiyama C; Mikami T; Yagita H; Uchiyama Y; Nakano H
    J Allergy Clin Immunol; 2019 Jan; 143(1):213-228.e10. PubMed ID: 29596938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation.
    Bonnet MC; Preukschat D; Welz PS; van Loo G; Ermolaeva MA; Bloch W; Haase I; Pasparakis M
    Immunity; 2011 Oct; 35(4):572-82. PubMed ID: 22000287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice.
    Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J
    PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis.
    Kumari S; Redouane Y; Lopez-Mosqueda J; Shiraishi R; Romanowska M; Lutzmayer S; Kuiper J; Martinez C; Dikic I; Pasparakis M; Ikeda F
    Elife; 2014 Dec; 3():. PubMed ID: 25443631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF Is Partially Required for Cell-Death-Triggered Skin Inflammation upon Acute Loss of cFLIP.
    Feoktistova M; Makarov R; Leverkus M; Yazdi AS; Panayotova-Dimitrova D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8.
    Wittkopf N; Günther C; Martini E; He G; Amann K; He YW; Schuchmann M; Neurath MF; Becker C
    Gastroenterology; 2013 Dec; 145(6):1369-79. PubMed ID: 24036366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury.
    Quintana A; Giralt M; Rojas S; Penkowa M; Campbell IL; Hidalgo J; Molinero A
    J Neurosci Res; 2005 Dec; 82(5):701-16. PubMed ID: 16267827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.
    Piao X; Komazawa-Sakon S; Nishina T; Koike M; Piao JH; Ehlken H; Kurihara H; Hara M; Van Rooijen N; Schütz G; Ohmuraya M; Uchiyama Y; Yagita H; Okumura K; He YW; Nakano H
    Sci Signal; 2012 Dec; 5(255):ra93. PubMed ID: 23250397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant accumulation of interleukin-10-secreting neutrophils in TRAF2-deficient mice.
    Piao JH; Yagita H; Okumura K; Nakano H
    Immunol Cell Biol; 2012 Oct; 90(9):881-8. PubMed ID: 22546736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes.
    Banno T; Gazel A; Blumenberg M
    J Biol Chem; 2005 May; 280(19):18973-80. PubMed ID: 15722350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.
    Jiang Y; Yu M; Hu X; Han L; Yang K; Ba H; Zhang Z; Yin B; Yang XP; Li Z; Wang J
    Cell Death Differ; 2017 Apr; 24(4):660-671. PubMed ID: 28186502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells.
    Wang Y; Zhao YR; Zhang AY; Ma J; Wang ZZ; Zhang X
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2087-2097. PubMed ID: 28537677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition.
    Feng Y; Teitelbaum DH
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(2):G236-49. PubMed ID: 22075779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L.
    Taraborrelli L; Peltzer N; Montinaro A; Kupka S; Rieser E; Hartwig T; Sarr A; Darding M; Draber P; Haas TL; Akarca A; Marafioti T; Pasparakis M; Bertin J; Gough PJ; Bouillet P; Strasser A; Leverkus M; Silke J; Walczak H
    Nat Commun; 2018 Sep; 9(1):3910. PubMed ID: 30254289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
    Manam S; Thomas JD; Li W; Maladore A; Schripsema JH; Ramsey KH; Murthy AK
    J Infect Dis; 2015 Jun; 211(12):2014-22. PubMed ID: 25552370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.
    Arnott CH; Scott KA; Moore RJ; Robinson SC; Thompson RG; Balkwill FR
    Oncogene; 2004 Mar; 23(10):1902-10. PubMed ID: 14661063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells.
    Oshima H; Ishikawa T; Yoshida GJ; Naoi K; Maeda Y; Naka K; Ju X; Yamada Y; Minamoto T; Mukaida N; Saya H; Oshima M
    Oncogene; 2014 Jul; 33(29):3820-9. PubMed ID: 23975421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
    Goodall LJ; Ovecka M; Rycroft D; Friel SL; Sanderson A; Mistry P; Davies ML; Stoop AA
    PLoS One; 2015; 10(9):e0137065. PubMed ID: 26352810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.
    Miller PG; Bonn MB; McKarns SC
    J Immunol; 2015 Sep; 195(6):2633-47. PubMed ID: 26268655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.